Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

The majority of treatment options for cancers are ineffective due to limited therapeutic targeting. Here, the authors develop bispecific antibodies that effectively target nanomaterials to triple-negative breast cancer cell receptors and deliver therapeutics leading to inhibition of tumour growth.

Guardado en:
Detalles Bibliográficos
Autores principales: Yu-Cheng Su, Pierre-Alain Burnouf, Kuo-Hsiang Chuang, Bing-Mae Chen, Tian-Lu Cheng, Steve R. Roffler
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/aa11269ebeb14aaca28beb8fce230033
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares